시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 조루 치료 시장 보고서(2025년)
Premature Ejaculation Treatment Global Market Report 2025
상품코드 : 1694820
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,281,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,078,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,876,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

조루 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 9.6%로 61억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 성 건강에 대한 지속적인 관심, 맞춤 치료 접근법, 성기능 장애에 대한 전 세계적인 노력, 온라인 건강 플랫폼 및 앱, 헬스케어에 대한 논의의 개방성 등이 성장에 영향을 미칠 것으로 보입니다. 예측 기간의 주요 동향으로는 행동치료 및 정신성애 치료 증가, 새로운 국소 치료법 개발, 약리학적 치료의 발전, 원격의료와 온라인 플랫폼의 통합, 환자 교육 및 상담의 중요성, 새로운 작용기전 연구 등이 있습니다.

성기능 장애의 유병률 증가는 향후 조루 치료 시장의 성장을 가속할 것으로 예상됩니다. 성 장애(성기능 장애)는 정기적인 친밀한 활동의 모든 단계에서 개인이 경험하는 어려움을 말합니다. 조루증은 남성에게 흔한 성기능 장애이며, 조루증을 관리하고 통제하기 위해서는 약수처리 및 치료적 접근과 같은 표적 치료가 필요합니다. 예를 들어, 영국에 기반을 둔 처방전 치료 서비스를 제공하는 Click2Pharmacy가 2022년 7월에 실시한 조사에 따르면, 영국 남성의 약 58.2%가 발기부전을 경험한 것으로 나타났습니다. 특히 25세에서 34세 남성 4명 중 3명이 2022년에 발기부전을 경험했다고 보고했습니다. 이러한 성장애 유병률 증가는 조루 치료 수요를 견인하며 시장 성장을 가속하고 있습니다.

성 건강에 대한 인식이 높아짐에 따라 조루 치료 시장의 성장이 더욱 촉진될 것으로 예상됩니다. 성 건강은 신체적, 정서적, 인지적, 사회적 측면을 포함한 전인적 웰빙을 포함합니다. 효과적인 조루 치료를 위해서는 성 건강에 대한 인식 개선이 필수적이며, 이해, 소통, 정보에 입각한 의사결정을 촉진하기 위해 2023년 10월 영국 정부 기관인 영국 보건안전국은 성 건강 서비스(SHS)의 상담 건수가 2023년까지 2022년에는 총 4,394,404건에 달했다고 보고했습니다. 이는 전년 대비 8.2% 증가한 수치로, 2021년에는 4,059,608건이었습니다. 따라서 성 건강에 대한 인식 증가는 조루 치료 시장의 성장을 가속하는 데 중요한 역할을 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Premature ejaculation treatment involves the use of medication or therapy to address and manage the symptoms of premature ejaculation. This type of treatment encompasses the application of medicines or therapeutic interventions to tackle and alleviate premature ejaculation.

The main types of premature ejaculation treatments include antidepressants (SSRIs), phosphodiesterase-5 inhibitors, topical anesthetics, analgesics, and other therapeutic options. Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressant medications commonly used for treating depression. These treatments can be administered orally or topically and may be obtained through retail or direct-to-consumer channels. Various applications for premature ejaculation treatments include hospitals, retail pharmacies, online pharmacies, and other healthcare settings.

The premature ejaculation treatment market research report is one of a series of new reports from The Business Research Company that provides premature ejaculation treatment market statistics, including premature ejaculation treatment industry global market size, regional shares, competitors with a premature ejaculation treatment market share, detailed premature ejaculation treatment market segments, market trends and opportunities, and any further data you may need to thrive in the premature ejaculation treatment industry. This premature ejaculation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The premature ejaculation treatment market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.27 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of premature ejaculation, growing awareness and reduced stigma, physician and patient education, changing societal attitudes toward sexual health, expansion of telemedicine services, pharmaceutical industry initiatives.

The premature ejaculation treatment market size is expected to see strong growth in the next few years. It will grow to $6.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to continued focus on sexual health, individualized treatment approaches, global efforts to address sexual dysfunction, online health platforms and apps, increased openness in healthcare discussions. Major trends in the forecast period include rise in behavioral and psychosexual therapies, development of novel topical therapies, advancements in pharmacological treatments, integration of telemedicine and online platforms, focus on patient education and counseling, research on novel mechanisms of action.

The increasing prevalence of sexual disorders is expected to propel the growth of the premature ejaculation treatment market going forward. Sexual disorders, or dysfunctions, refer to difficulties that individuals experience during any phase of regular intimate activity. Premature ejaculation, a common sexual disorder among men, requires targeted treatments such as medications or therapeutic approaches to manage and control the condition. For instance, a survey conducted in July 2022 by Click2Pharmacy, a UK-based provider of local prescription treatment services, revealed that around 58.2% of men in the UK experienced erectile dysfunction. Notably, three in four men aged 25 to 34 reported experiencing erectile dysfunction in 2022. The growing prevalence of such sexual disorders is driving the demand for premature ejaculation treatment, fueling the market's growth.

The rise in awareness about sexual health is expected to further fuel the growth of the premature ejaculation treatment market. Sexual health encompasses holistic well-being, including the physical, emotional, cognitive, and social dimensions of one's sexuality. Increased awareness about sexual health is crucial for effective premature ejaculation treatment, fostering understanding, communication, and informed decision-making. In October 2023, the UK Health Security Agency, a UK-based government agency, reported a notable increase in consultations at sexual health services (SHSs), reaching a total of 4,394,404 in 2022. This represented an 8.2% rise from the previous year, with the count standing at 4,059,608 in 2021. Therefore, the growing awareness about sexual health is playing a significant role in propelling the growth of the premature ejaculation treatment market.

Key companies in the premature ejaculation treatment market are focusing on developing new solutions, such as delay sprays, to drive revenues. Delay sprays are specially formulated products applied to the penis before sexual activity to help men last longer during intercourse. They work by temporarily dulling penis nerves, reducing penis sensitivity, and delaying ejaculation. For instance, in August 2023, Maude, a US-based sexual wellness company, introduced Stay, a delay spray explicitly designed to address premature ejaculation. This product contains 10% lidocaine, a fast-evaporating local anesthetic that reduces sensitivity in the male genital region. Stay is compatible with both latex and polyisoprene condoms, various lubricants, and devices. It is vegan-friendly, fragrance-free, and free from sulfates, silicones, and parabens.

In September 2022, Advanced MedTech Holdings (AMTH), a Singapore-based medical technology manufacturing company, acquired Shenzhen Wikkon Medical Apparatus Co. Ltd. for an undisclosed amount. This acquisition enhances AMTH's footprint in China and broadens its global urology platform. By combining WIKKON's innovative technologies with AMTH's extensive resources, the acquisition positions the company to better serve both domestic and international markets. Shenzhen Wikkon Medical Apparatus Co. Ltd. is a China-based medical device company specializing in urology and shock wave therapy devices, as well as treatments for premature ejaculation.

Major companies operating in the premature ejaculation treatment market report are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Menarini Group, Lupin Limited., Amneal Pharmaceuticals Inc., Mankind Pharma Ltd., Cipla Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Sagent Pharmaceuticals Inc., Vivus Inc., Absorption Pharmaceuticals LLC, Innovus Pharmaceuticals Inc., Sunrise Pharmaceuticals Inc., Solco Healthcare US LLC, Apricus Biosciences Inc., Regent Pacific Group Limited, Endurance RP Ltd.

North America was the largest region in the premature ejaculation treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the premature ejaculation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the premature ejaculation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The premature ejaculation treatment market includes revenues earned by entities by providing services such as psychological therapy, cognitive-behavioral therapy and behavioral therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The premature ejaculation treatment market consists of sales of medications, inhibitors and drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Premature Ejaculation Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on premature ejaculation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for premature ejaculation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The premature ejaculation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Premature Ejaculation Treatment Market Characteristics

3. Premature Ejaculation Treatment Market Trends And Strategies

4. Premature Ejaculation Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Premature Ejaculation Treatment Growth Analysis And Strategic Analysis Framework

6. Premature Ejaculation Treatment Market Segmentation

7. Premature Ejaculation Treatment Market Regional And Country Analysis

8. Asia-Pacific Premature Ejaculation Treatment Market

9. China Premature Ejaculation Treatment Market

10. India Premature Ejaculation Treatment Market

11. Japan Premature Ejaculation Treatment Market

12. Australia Premature Ejaculation Treatment Market

13. Indonesia Premature Ejaculation Treatment Market

14. South Korea Premature Ejaculation Treatment Market

15. Western Europe Premature Ejaculation Treatment Market

16. UK Premature Ejaculation Treatment Market

17. Germany Premature Ejaculation Treatment Market

18. France Premature Ejaculation Treatment Market

19. Italy Premature Ejaculation Treatment Market

20. Spain Premature Ejaculation Treatment Market

21. Eastern Europe Premature Ejaculation Treatment Market

22. Russia Premature Ejaculation Treatment Market

23. North America Premature Ejaculation Treatment Market

24. USA Premature Ejaculation Treatment Market

25. Canada Premature Ejaculation Treatment Market

26. South America Premature Ejaculation Treatment Market

27. Brazil Premature Ejaculation Treatment Market

28. Middle East Premature Ejaculation Treatment Market

29. Africa Premature Ejaculation Treatment Market

30. Premature Ejaculation Treatment Market Competitive Landscape And Company Profiles

31. Premature Ejaculation Treatment Market Other Major And Innovative Companies

32. Global Premature Ejaculation Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Premature Ejaculation Treatment Market

34. Recent Developments In The Premature Ejaculation Treatment Market

35. Premature Ejaculation Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기